Aging research has shifted from chasing one cause to targeting many. A handful of peptides keep showing up in the lab because each one nudges a different "hallmark of aging." Here is a tour of five of the most studied compounds and what scientists think they actually do.
The Hallmarks Framework
Modern aging biology rests on a list of nine to twelve "hallmarks." These include telomere wear, mitochondrial decline, loss of stem cells, and runaway inflammation. Each hallmark is a possible target for a drug or peptide.
Peptides are short chains of amino acids. They can mimic natural signals in the body, slip into specific receptors, or carry metals into tissue. That makes them useful tools for testing aging theories one hallmark at a time.
Epitalon and Telomere Biology
Epitalon is a four amino acid peptide built from the pineal extract epithalamin. Russian researchers led by Khavinson reported that it can switch on telomerase, the enzyme that protects chromosome ends. In cell culture, exposed human cells extended their telomeres and divided past their usual limits.
Animal work has linked Epitalon to changes in melatonin rhythms and antioxidant gene expression. The data are interesting but mostly come from a single research lineage, so independent replication still matters.
NAD+ and MOTS-c: Mitochondrial Signals
NAD+ is not a peptide, but it sits at the center of peptide aging research. It fuels the sirtuin enzymes that read the genome and tune metabolism. Verdin (2015) reviewed how falling NAD+ levels cripple this system in older tissue. Yoshino et al. (2011) showed that restoring NAD+ in aged mice fixed glucose handling and mitochondrial output.
MOTS-c is a tiny peptide encoded inside mitochondrial DNA itself. It activates AMPK, the cellular "low fuel" sensor, and pushes cells toward exercise-like metabolism. In rodent studies it improved insulin sensitivity and physical endurance, even in older animals.
GHK-Cu and SS-31: Tissue and Membrane Repair
GHK-Cu is a copper-binding tripeptide first isolated from human plasma by Pickart in the 1970s. Gene expression studies suggest it shifts thousands of genes toward repair, including ones tied to skin remodeling and wound closure. Researchers also study it for hair follicle signaling and extracellular matrix turnover.
SS-31, also called elamipretide, targets a fat called cardiolipin in the inner mitochondrial membrane. By stabilizing cardiolipin, it helps mitochondria keep making ATP under stress. Preclinical work spans heart failure, kidney injury, and age-related muscle weakness.
Bringing the Hallmarks Together
None of these peptides is a single magic bullet. Each one targets a different hallmark: telomere maintenance, NAD+ depletion, mitochondrial signaling, gene expression, and membrane integrity. That is why aging labs often study them side by side rather than head to head.
Open questions still dominate the field. Researchers are working out which combinations are safe, how dose timing changes outcomes, and whether benefits seen in mice carry over to larger animals. Most of these compounds remain in preclinical or early clinical stages, with mixed and sometimes underpowered data. These compounds are sold strictly for in vitro laboratory research and are not approved for human consumption.